TP53 and neoplasm: So far, MDM2-ALT2 studies have presented seemingly contrasting findings, demonstrating that MDM2-ALT2 can inhibit tumor growth in a p53-dependent manner as well as enhancing transformation and displaying p53-independent oncogenic activity in a context-dependent manner [12,13,17].